SEARCH RESULT

Total Matching Records found : 542

Drug regulator cover on vaccine study aim by GS Mudur

India’s drug regulator has refused to disclose key information about a controversial government study that provided Indian girls a vaccine designed to protect them from cervical cancer, amplifying suspicions about the study’s objectives. The Drug Controller General of India (DCGI) has refused to release for public scrutiny the study’s protocols, which are expected to contain information about its purpose and methodology, a set of health activists said yesterday. The Union government had...

More »

Threats shadow activists by Pallavi Singh & Maitreyee Handique

At least 10 RTI applicants have been killed over the past two years, with many others facing threats in their bid to expose corruption On a Republic Day when India celebrated 61 years of justice, equality and liberty, Amar Nath Pandey says he encountered the darkest moment of his life. In late evening on 26 January, a lone assailant leaped from the folds of darkness in the street outside his house in...

More »

The tenacity of hope by Dipankar Gupta

Since Cairo took to the streets, there is one question that comes up repeatedly in India. How have we been saved from such anarchy, in spite of our faltering democracy? True, Egypt's growth, between 5% and 7%, has been less spectacular than ours. But its per capita income swelled from $587 in 1981 to $1461 in 2001. Even its deficit as a percentage of GDP has fallen from 10.2% in...

More »

Panel finds deficiencies in HPV vaccine project by Aarti Dhar

Rules out blanket ban on or approval of such studies ‘HPV vaccination should supplement cervical cancer screening programme' The three-member committee, set up to probe the alleged irregularities in conducting studies using human papillomavirus (HPV) vaccine by PATH in India, has identified several deficiencies in the planning and implementation of the project leading “to a crisis requiring suspension of the study,” but has fallen short of fixing responsibility on any individual or...

More »

Govt explores capping FDI in pharma by CH Unnikrishnan

The Indian government is exploring a proposal to reduce the limit on foreign direct investment (FDI) allowed in the pharmaceutical industry through the automatic route to 49% from 100% amid concerns over the takeover of local drug makers by overseas firms. Officials from the ministry of commerce and industry and the ministry of health have had multiple rounds of discussions on the proposal following a note written to them by the finance...

More »

Video Archives

Archives

share on Facebook
Twitter
RSS
Feedback
Read Later

Contact Form

Please enter security code
      Close